Can cartilage intermediate layer protein 1 (CILP1) use as a novel biomarker for canine myxomatous mitral valve degeneration levels or not?

BACKGROUND: Myxomatous mitral valve degeneration (MMVD) is the most common degenerative heart disease in dogs and is associated with irreversible changes in the valve tissue. Although traditional cardiac biomarkers are efficient for diagnosing MMVD, there are limitations, therefore, it is important...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyeon-Jin, Kim, Jihyun, Kim, Soomin, Kim, Ha-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990206/
https://www.ncbi.nlm.nih.gov/pubmed/36882760
http://dx.doi.org/10.1186/s12917-023-03583-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990206/
https://www.ncbi.nlm.nih.gov/pubmed/36882760
http://dx.doi.org/10.1186/s12917-023-03583-7

Ejemplares similares